Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Sarcoma 1Dermatologic 1CNS 1

Conditions

Thyroid Neoplasms 1Sarcoma 1Pheochromocytoma 1Paraganglioma 1Neoplastic Syndromes, Hereditary 1Melanoma 1Kidney Neoplasms 1Hematologic Neoplasms 1Glioma 1Bone Neoplasms 1

Interventions

Cyclophosphamide 4fludarabine phosphate 3fludarabine 2Whole-Body Irradiation 2Tacrolimus 2Mycophenolic Acid 2Cytarabine 2Azacitidine 2venetoclax 1thymoglobulin 1tazemetostat 1romidepsin 1quizartinib 1plerixafor 1glucarpidase 1cc-486 1capmatinib 1aldesleukin 1Zoledronic Acid 1Vincristine 1Transplantation 1Thiotepa 1Spironolactone 1Rituximab 1Rifampin 1Pravastatin 1Polymerase Chain Reaction 1Palliative Care 1Methotrexate 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Genetic Testing × Sarcoma × Clear all
NCT01772771 2026-03-03

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

M.D. Anderson Cancer Center

Recruiting
12,000 enrolled
CNSDermatologicOther hematologic neoplasmSarcoma

Glioma, Melanoma, Sarcoma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡